Patients with disabilities encounter challenges in accessing clinical trials for new treatments

Patients with disabilities often struggle to access clinical trials for new treatments. Barriers include reluctance from pharmaceutical companies and healthcare providers, who may fear causing harm or complications for these patients. Leanne Duggan, diagnosed with advanced pancreatic cancer, faced significant challenges but was eventually accepted into a clinical trial for a targeted drug therapy. Her medical team worked hard to ensure the trial was accessible, leading to positive results in her treatment. Since starting the trial, Duggan's tumor markers have significantly decreased, and she is experiencing improved health. She credits her medical team for advocating on her behalf, which she believes was crucial for her survival.